Key facts
- Notable investors include Fosun Health Capital, Fosun Pharma.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Hengtai Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Hengtai Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hengtai Bio
Manufacturer of pharmaceutical products focused on advancing biopharmaceutical innovation and market expansion. The company specialises in drug formulation development, active pharmaceutical ingredient production and clinical trial support, thereby helping accelerate access to high-quality therapeutics and drive growth in the biopharma sector.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Hengtai Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hengtai Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hengtai Bio in its N-PORT filings yet. We sweep new filings monthly.